ASX - By Stock
|
MSB |
Re:
ASX Hot too!
|
|
degen
|
463 |
141K |
2 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
463
|
141K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
ASX Hot too!
|
|
degen
|
463 |
141K |
1 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
463
|
141K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB $1 Party
|
|
degen
|
1.1K |
340K |
19 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
1.1K
|
340K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
ASX Hot too!
|
|
degen
|
463 |
141K |
5 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
463
|
141K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
MSB $1 Party
|
|
degen
|
1.1K |
340K |
6 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
1.1K
|
340K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
ASX Hot too!
|
|
degen
|
463 |
141K |
2 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
463
|
141K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
ASX Hot too!
|
|
degen
|
463 |
141K |
7 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
463
|
141K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Valuation
|
|
degen
|
89 |
44K |
2 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
89
|
44K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
ASX Hot too!
|
|
degen
|
463 |
141K |
12 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
463
|
141K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Application for quotation of securities - MSB
|
|
degen
|
1 |
917 |
4 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
1
|
917
|
4
|
|
ASX - By Stock
|
MGX |
Re:
Ann: On Track for FY24 Shipping Guidance
|
|
degen
|
6 |
1.8K |
3 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
6
|
1.8K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
degen
|
590 |
223K |
3 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
590
|
223K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MSB $1 Party
|
|
degen
|
1.1K |
340K |
6 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
1.1K
|
340K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
degen
|
551 |
200K |
6 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
551
|
200K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
degen
|
551 |
200K |
25 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
551
|
200K
|
25
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
degen
|
226 |
77K |
3 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
226
|
77K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
degen
|
226 |
77K |
5 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
226
|
77K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
degen
|
9.5K |
2.8M |
4 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
9.5K
|
2.8M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
degen
|
549 |
172K |
2 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
549
|
172K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
degen
|
549 |
172K |
16 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
549
|
172K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
degen
|
549 |
172K |
18 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
549
|
172K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
degen
|
590 |
223K |
14 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
590
|
223K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
degen
|
590 |
223K |
9 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
590
|
223K
|
9
|
|
ASX - By Stock
|
MAN |
Re:
Ann: High grade uranium up to 0.55% U3O8 at surface
|
|
degen
|
26 |
8.0K |
1 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
26
|
8.0K
|
1
|
|
ASX - By Stock
|
MAN |
Re:
Ann: Uranium Exploration Update
|
|
degen
|
36 |
9.0K |
3 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
36
|
9.0K
|
3
|
|
ASX - By Stock
|
MAN |
Re:
Ann: Uranium Exploration Update
|
|
degen
|
36 |
9.0K |
1 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
36
|
9.0K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 3Ys- J Swedish,B Burns,J Bell,P Krause,P Facchina
|
|
degen
|
11 |
4.2K |
12 |
28/12/23 |
28/12/23 |
ASX - By Stock
|
11
|
4.2K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Taken up the entitlement?
|
|
degen
|
544 |
131K |
16 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
544
|
131K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
degen
|
716 |
198K |
4 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
716
|
198K
|
4
|
|
ASX - By Stock
|
KAR |
Re:
Equity raise.
|
|
degen
|
70 |
29K |
2 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
70
|
29K
|
2
|
|
ASX - By Stock
|
KAR |
Re:
Macquarie says Karoon worth $5.15 if oil > 100
|
|
degen
|
663 |
344K |
0 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
663
|
344K
|
0
|
|
ASX - By Stock
|
KAR |
Re:
Citi initiate with BUY
|
|
degen
|
1 |
637 |
1 |
07/11/23 |
07/11/23 |
ASX - By Stock
|
1
|
637
|
1
|
|
ASX - By Stock
|
KAR |
Re:
Ann: September 2023 Quarterly Report
|
|
degen
|
31 |
12K |
5 |
27/10/23 |
27/10/23 |
ASX - By Stock
|
31
|
12K
|
5
|
|
ASX - By Stock
|
MGX |
Re:
Ship tracking thread - only. Reading is optional
|
|
degen
|
639 |
213K |
0 |
10/10/23 |
10/10/23 |
ASX - By Stock
|
639
|
213K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Type A Meeting with FDA
|
|
degen
|
574 |
192K |
16 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
574
|
192K
|
16
|
|
ASX - By Stock
|
MGX |
Re:
Ann: Koolan Island Update
|
|
degen
|
6 |
2.5K |
5 |
07/08/23 |
07/08/23 |
ASX - By Stock
|
6
|
2.5K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
How much money MSB will need to raise till approval ?
|
|
degen
|
8 |
2.7K |
3 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
8
|
2.7K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
degen
|
1.0K |
391K |
7 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
391K
|
7
|
|
ASX - By Stock
|
MGX |
Re:
Ship tracking thread - only. Reading is optional
|
|
degen
|
639 |
213K |
2 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
639
|
213K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
degen
|
1.3K |
546K |
1 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
1.3K
|
546K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
degen
|
1.3K |
546K |
3 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
1.3K
|
546K
|
3
|
|
ASX - By Stock
|
MGX |
Re:
Ship tracking thread - only. Reading is optional
|
|
degen
|
639 |
213K |
3 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
639
|
213K
|
3
|
|
ASX - By Stock
|
KAR |
Re:
Ann: June 2023 Quarterly Report
|
|
degen
|
57 |
21K |
15 |
28/07/23 |
28/07/23 |
ASX - By Stock
|
57
|
21K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
degen
|
17K |
6.6M |
9 |
28/07/23 |
28/07/23 |
ASX - By Stock
|
17K
|
6.6M
|
9
|
|
ASX - By Stock
|
MAN |
Re:
Ann: Regional continuity of Lithium brine reservoir gives scale
|
|
degen
|
131 |
30K |
6 |
27/07/23 |
27/07/23 |
ASX - By Stock
|
131
|
30K
|
6
|
|
ASX - By Stock
|
BPT |
Re:
Ann: FY23 Fourth Quarter Activities Report
|
|
degen
|
30 |
12K |
6 |
26/07/23 |
26/07/23 |
ASX - By Stock
|
30
|
12K
|
6
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MESO watch and banter
|
|
degen
|
400 |
149K |
3 |
25/07/23 |
25/07/23 |
ASX - By Stock
|
400
|
149K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
degen
|
3.4K |
1.1M |
4 |
25/07/23 |
25/07/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
4
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MESO watch and banter
|
|
degen
|
400 |
149K |
4 |
24/07/23 |
24/07/23 |
ASX - By Stock
|
400
|
149K
|
4
|
|
ASX - By Stock
|
MAN |
Re:
Ann: 3D seismic enhances Lithium exploration
|
|
degen
|
291 |
38K |
4 |
21/07/23 |
21/07/23 |
ASX - By Stock
|
291
|
38K
|
4
|
|